1-2 of 2
Siyao Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II trial of obinutuzumab, ibrutinib and venetoclax in patients with previously untreated follicular lymphoma; A University of California hematologic malignancies consortium study

Free
Aneeqa Zafar, Naseem Esteghamat, Haifaa Abdulhaq, Shuai Chen, Siyao Li, Paul Kaesberg, Rasmus Hoeg, Aaron Tsumura, Benjamin Heyman, Patricia A. Young, Sani Bukari, Carolyn Mulroney, Herbert Eradat, Aaron Rosenberg, Joseph Tuscano
Journal: Blood
Blood (2025) 146 (Supplement 1): 5378.
https://doi.org/10.1182/blood-2025-5378
Published: 2025
Journal Articles

Efficacy and safety of loncastuximab tesirine and rituximab (Lonca-R) followed by dose-adjusted rituximab with etoposide, doxorubicin, cyclophosphamide, vincristine and prednisone (DA-R-EPOCH) in previously untreated high-risk diffuse large B-cell lymphoma (DLBCL): Preliminary results from a University of California Malignancy Consortium (UCHMC) Phase II trial, UCDCC#303.

Free
Jacqueline Hsieh-Wong, Naseem Esteghamat, Rasmus Hoeg, Mehrdad Abedi, Sheila Firoozan, Aaron Rosenberg, Ashley Trane, Aneeqa Zafar, Shuai Chen, Siyao Li, Matthew Wieduwilt, Lloyd Damon, Benjamin Heyman, Haifaa Abdulhaq, Elizabeth Brem, Deepa Jeyakumar, Gary Schiller, Joseph Tuscano
Journal: Blood
Blood (2025) 146 (Supplement 1): 1966.
https://doi.org/10.1182/blood-2025-1966
Published: 2025